Mostrando 1 - 5 Resultados de 5 Para Buscar '"P.O.D"', tiempo de consulta: 2.71s Limitar resultados
  1. 1
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Congenital anomalies in multiple births after early loss of a conceptus
  2. 2
    “…RESULTS: The patient recovered well, with a progressive improvement of the general conditions, and was finally discharged on p.o.d. 14. No anastomotic defects were found at the postoperative CT scan 10 months after the surgery. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Extra-Anatomic Jump Graft from the Right Colic Vein: A Novel Technique to Manage Portal Vein Thrombosis in Liver Transplantation
  3. 3
    “…In the HCT116 xenograft model, the compound (170 mg/kg, i.p., o.d., 10 days) provided a T/C ratio close to 60% on day 8 after the treatment was completed. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Synthesis and Biological Evaluation of Novel Dispiro-Indolinones with Anticancer Activity
  4. 4
    “…RESULTS: Marked amelioration of hepatic injuries by attenuation of serum and lipid peroxidation has been observed as comparable with silymarin (25 mg/kg p.o). D-GalN/LPS induced significant decrease in oxidative stress markers protein level, and albumin. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatoprotective activity of Lepidium sativum seeds against D-galactosamine/lipopolysaccharide induced hepatotoxicity in animal model
  5. 5
    “…The regimen was as follows: toripalimab (240 mg, i.v., d1), gemcitabine (1,000 mg/m(2), i.v., d1 and d8), and S-1 (40–60 mg bid p.o., d1–14, Q21d). The primary endpoint was progression-free survival. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Toripalimab in advanced biliary tract cancer
Herramientas de búsqueda: RSS